FDA Inspection
VCU Health System Reproductive Medicine and IVFVCU Health System Reproductive Medicine and IVF – FDA Inspection, Nov 14, 2024
Record Details
This FDA Inspection record concerns VCU Health System Reproductive Medicine and IVF, with an inspection on November 14, 2024, issued by the Baltimore District Office, covering biologics.
- Inspection Date
- November 14, 2024
- Product Type
- Biologics
View Company Profile
ID · efd7f1f1-588a-4715-bca6-64cb7d0f711c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1254107
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.75(d)Donors with risks not determined ineligible
Full citation text and observation details available on the Dashboard.
Other FDA inspections of VCU Health System Reproductive Medicine and IVF
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 14, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 12, 2023 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 28, 2021 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 1, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for VCU Health System Reproductive Medicine and IVF
- FDA Inspection 1343268 - 2026-10-14
- FDA Inspection 1205700 - 2023-05-12
- FDA Inspection 1143572 - 2021-05-28
- FDA Inspection 1031840 - 2017-11-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.